(Q40604679)

22 September 2017

title

Which children with fever and neutropenia can be safely treated as outpatients? (English)

1 reference

22 September 2017

Mullen CA

1

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

British Journal of Haematology

22 September 2017

published in

1 reference

22 September 2017

volume

112

1 reference

22 September 2017

issue

4

1 reference

22 September 2017

page(s)

832-837

1 reference

Early discharge of low-risk febrile neutropenic children and adolescents with cancer

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02632.X

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02632.X

A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02632.X

A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Can

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02632.X

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02632.X

Infection risk factors in febrile, neutropenic children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02632.X

Early discharge of pediatric febrile neutropenic cancer patients by substitution of oral for intravenous antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02632.X

The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02632.X

Economic and resource utilization analysis of outpatient management of fever and neutropenia in low-risk pediatric patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02632.X

Fever and neutropenia in pediatric hematopoietic stem cell transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02632.X

A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02632.X

Research advances in oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02632.X

Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02632.X

Management of fever in patients with cancer and treatment-induced neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02632.X

Duration of empiric antibiotic therapy in granulocytopenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02632.X

Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02632.X

Predicting the risk of bacteremia in childen with fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02632.X

Early empiric antibiotic therapy for febrile neutropenia patients at low risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02632.X

The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02632.X

Controversies in new antibiotic therapy for ambulatory patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02632.X

The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02632.X

Differences between first and subsequent fevers during prolonged neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02632.X

10.1046/J.1365-2141.2001.02632.X

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference